Here we go. A new variant of the COVID virus identified in South Africa is “highly transmissible and vaccine-resistant.” BioNTech/Pfizer on Friday said it will know its vaccine effectiveness against the new ‘Omicron’ variant within a couple weeks. “We expect more data from the laboratory tests in two weeks at the latest. These data will…